Acceleron Pharma Inc (OQ:XLRN)

Business Focus: Bio Therapeutic Drugs

Recent Price for XLRN
USD 26.185 -0.285 (-1.077%)
NASDAQ Delayed 15 minutes
10:03 EST
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
26.560 41.690 N/A 17,351 988.39
1-Day Low 52-Week Low Yield Avg. Volume  
26.050 22.670 0.0% 395,123  

Latest 10 SEC filings (by transaction date) for XLRN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Jan 6/17 Jan 4/17 Kumar Ravindra Direct Ownership Common Stock S - Open market or private sale -1,641 $27.60
Jan 6/17 Jan 4/17 Kumar Ravindra Direct Ownership Common Stock S - Open market or private sale -359 $26.81
Jan 6/17 Jan 4/17 Quisel John D Direct Ownership Common Stock S - Open market or private sale -1,400 $27.56
Jan 6/17 Jan 4/17 Quisel John D Direct Ownership Common Stock S - Open market or private sale -300 $26.43
Jan 6/17 Jan 4/17 Mclaughlin Kevin F Direct Ownership Common Stock S - Open market or private sale -1,300 $27.63
Jan 6/17 Jan 4/17 Mclaughlin Kevin F Direct Ownership Common Stock S - Open market or private sale -400 $26.87
Jan 6/17 Jan 4/17 Sherman Matthew L Direct Ownership Common Stock S - Open market or private sale -1,600 $27.62
Jan 6/17 Jan 4/17 Sherman Matthew L Direct Ownership Common Stock S - Open market or private sale -400 $26.81
Jan 6/17 Jan 4/17 Ertel Steven D Direct Ownership Common Stock S - Open market or private sale -1,900 $27.61
Jan 6/17 Jan 4/17 Ertel Steven D Direct Ownership Common Stock S - Open market or private sale -600 $26.92
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for XLRN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Jan 6/17 Jan 4/17 Kumar Ravindra Direct Ownership Common Stock S - Open market or private sale -1,641 $27.60
Jan 6/17 Jan 4/17 Kumar Ravindra Direct Ownership Common Stock S - Open market or private sale -359 $26.81
Jan 6/17 Jan 4/17 Quisel John D Direct Ownership Common Stock S - Open market or private sale -1,400 $27.56
Jan 6/17 Jan 4/17 Quisel John D Direct Ownership Common Stock S - Open market or private sale -300 $26.43
Jan 6/17 Jan 4/17 Mclaughlin Kevin F Direct Ownership Common Stock S - Open market or private sale -1,300 $27.63
Jan 6/17 Jan 4/17 Mclaughlin Kevin F Direct Ownership Common Stock S - Open market or private sale -400 $26.87
Jan 6/17 Jan 4/17 Sherman Matthew L Direct Ownership Common Stock S - Open market or private sale -1,600 $27.62
Jan 6/17 Jan 4/17 Sherman Matthew L Direct Ownership Common Stock S - Open market or private sale -400 $26.81
Jan 6/17 Jan 4/17 Ertel Steven D Direct Ownership Common Stock S - Open market or private sale -1,900 $27.61
Jan 6/17 Jan 4/17 Ertel Steven D Direct Ownership Common Stock S - Open market or private sale -600 $26.92
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Share an Idea with Easy Blurb
140

Twitter

Search (past week) for $XLRN

StockTwits